— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the...
AMSTERDAM, April 16, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI) ("OCI" or the "Company") today confirms that further to its announcement to pay an...
Ontic's unified platform empowers corporate security teams to manage threats, mitigate risks, and make businesses stronger. SAN ANTONIO, April 16, 2025 /PRNewswire/ -- Frost...
SUZHOU, China, April 16, 2025 /PRNewswire/ -- April 12, 2025, Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting...